Intracellular trafficking and fate of chimeric adenovirus 5/F35 in human B lymphocytes

Journal of Gene Medicine

Volumn 13, Issue 9, 2011, Pages 451-461

  Samson, Mélanie ^a   Jung, Daniel ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Ad5 F35; Adenovirus; B lymphocytes; Endocytic trafficking; Endocytosis; Lymphoid cell lines

Indexed keywords

ADENOVIRUS 5 F35 VECTOR; ADENOVIRUS VECTOR; CARBOCYANINE; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN;

ARTICLE; B LYMPHOCYTE; CHIMERA; ENDOCYTOSIS; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; LYMPHOID CELL LINE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TRANSGENE; VIRUS CELL INTERACTION;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD46; B-LYMPHOCYTES; BIOLOGICAL TRANSPORT; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; ENDOCYTOSIS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, VIRAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEK293 CELLS; HUMANS; INTRACELLULAR SPACE; PLASMA CELLS; TRANSDUCTION, GENETIC; TRANSGENES;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5;

EID: 80053427917     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1588     Document Type: Article

References (55)

1. Kay M, Glorioso J, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33-40.
2. Greber U, Kasamatsu H. Nuclear targeting of SV40 and adenovirus. Trends Cell Biol 1996; 6: 189-195.
3. Neering S, Hardy S, Minamoto D, Spratt S, Jordan C. Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood 1996; 88: 1147-1155.
4. Nevins J, DeGregori J, Jakoi L, Leone G. Functional analysis of E2F transcription factor. Methods Enzymol 1997; 283: 205-219.
5. Wilson J. Adenoviruses as gene-delivery vehicles. N Engl J Med 1996; 334: 1185-1187.
6. Ugolini S, Mondor I, Sattentau Q. HIV-1 attachment: another look. Trends Microbiol 1999; 7: 144-149.
7. Vlasak M, Goesler I, Blass D. Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment. J Virol 2005; 79: 5963-5970.
8. Young J. Virus entry and uncoating. In Fields Virology, (4th edn), Knipe DM, Howley PM (eds). Lippincott Williams & Wilkins: Philadelphia, PA, 2001; 87-103.
9. Dechecchi M, Melotti P, Bonizzato A, Santacatterina M, Chilosi M, Cabrini G. Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol 2001; 75: 8772-8780.
10. Marsh M, Helenius A. Virus entry: open sesame. Cell 2006; 124: 729-740.
11. Leopold P, Crystal R. Intracellular trafficking of adenovirus: many means to many ends. Adv Drug Deliv Rev 2007; 59: 810-821.
12. Meier O, Greber UF. Adenovirus endocytosis. J Gene Med 2003; 5: 451-462.
13. Mudhakir D, Harashima H. Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus. AAPS J 2009; 11: 65-77.
14. Marsh M, Helenius A. Virus entry into animal cells. Adv Virus Res 1989; 36: 107-151.
15. Mercer J, Helenius A. Virus entry by macropinocytosis. Nat Cell Biol 2009; 11: 510-520.
16. Mercer J, Schelhaas M, Helenius A. Virus entry by endocytosis. Annu Rev Biochem 2010; 79: 803-833.
17. Seth P. Adenovirus-dependent release of choline from plasma membrane vesicles at an acidic pH is mediated by the penton base protein. J Virol 1994; 68: 1204-1206.
18. Wiethoff C, Wodrich H, Gerace L, Nemerow G. Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol 2005; 79: 1992-2000.
19. Kelkar S, Pfister K, Crystal R, Leopold P. Cytoplasmic dynein mediates adenovirus binding to microtubules. J Virol 2004; 78: 10122-10132.
20. Havenga M, Lemckert A, Ophorst O, et al. Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease. J Virol 2002; 76: 4612-4620.
21. Knaän-Shanzer S, Van Der Velde I, Havenga M, et al. Highly efficient targeted transduction of undifferentiated human hematopoietic cells by adenoviral vectors displaying fiber knobs of subgroup B. J Virol 2001; 74: 2567-2583.
22. Shayakhmetov D, Papayannopoulou T, Stamatoyannopoulos G, Lieber A. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. J Virol 2000; 74: 2567-2583.
23. Gaggar A, Shayakhmetov D, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003; 9: 1408-1412.
24. Rea D, Havenga M, van Den Assem M, et al. Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J Immunol 2001; 166: 5236-5244.
25. Schroers R, Hildebrandt Y, Hasenkamp J, et al. Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors. Exp Hematol 2004; 32: 536-546.
26. Cayer M, Drouin M, Sea S, et al. Comparison of promoter activities for efficient expression into human B cells and haematopoietic progenitors with adenovirus Ad5/F3. Immunol Methods 2007; 322: 118-127.
27. Jung D, Neron S, Drouin M, Jacques A. Efficient gene transfer into normal human B lymphocytes with the chimeric adenoviral vector Ad5/F3. Immunol Methods 2005; 304: 78-87.
28. Nilsson M, Ljungberg J, Richter J, et al. Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells. J Gene Med 2004; 6: 631-641.
29. Yotnda P, Zompeta C, Heslop H, et al. Comparison of the efficiency of transduction of leukemic cells by fiber-modified adenoviruses. Hum Gene Ther 2004; 15: 1229-1242.
30. Drouin M, Cayer M, Jung D. Adenovirus 5 and chimeric adenovirus 5/F35 employ distinct B-lymphocyte intracellular trafficking routes that are independent of their cognate cell surface receptor. Virology 2010; 401: 305-313.
31. Fecteau J, Néron S. CD40 stimulation of human peripheral B lymphocytes: distinct response from naive and memory cells. J Immunol 2003; 171: 4621-4629.
32. Néron S, Racine C, Roy A, Guérin M. Differential responses of human B-lymphocyte subpopulations to graded levels of CD40-CD154 interaction. Immunology 2005; 116: 454-463.
33. Leopold P, Ferris B, Grinberg I, et al. Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum Gene Ther 1998; 9: 367.
34. Bolte S, Cordelières F. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 2006; 224: 213-232.
35. Proulx M, Cayer MP, Drouin M, Laroche A, Jung D. Overexpression of PAX5 induces apoptosis in multiple myeloma cells. Int J Hematol 2010; 92: 451-62.
36. Gall J, Kass-Eisler A, Leinwand L, Falck-Pedersen E. Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. J Virol 1996; 70: 2116-2123.
37. Nicklin S, Wu E, Nemerow G, Baker A. The influence of adenovirus fiber structure and function on vector development for gene therapy. Mol Ther 2005; 12: 384-393.
38. Miyazawa N, Leopold P, Hackett N, et al. Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J Virol 1999; 73: 6056-6065.
39. Marttila M, Persson D, Gustafsson D, et al. CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7. J Virol 2005; 79: 14429-14436.
40. Sirena D, Lilienfeld B, Eisenhut M, et al. The human membrane cofactor CD46 is a receptor for species B adenovirus serotype. Virol 2004; 78: 4454-4462.
41. Greber U. Signalling in viral entry. Cell Mol Life Sci 2002; 59: 608-626.
42. Frecha C, Lévy C, Costa C, et al. Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors. J Virol 2011; 85: 5975-5985.
43. Charras G, Coughlin M, Mitchison T, Mahadevan L. Life and times of a cellular bleb. Biophys J 2008; 94: 1836-1853.
44. Kielian M, Marsh M, Helenius A. Kinetics of endosome acidification detected by mutant and wild-type Semliki Forest virus. EMBO J 1986; 5: 3103-3109.
45. Lakadamyali M, Rust M, Zhuang X. Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 2006; 124: 997-1009.
46. Shayakhmetov D, Li Z, Ternovoi V, et al. The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses. J Virol 2003; 77: 3712-3723.
47. Pilecka I, Banach-Orlowska M, Miaczynska M. Nuclear functions of endocytic proteins. Eur J Cell Biol 2007; 86: 533-547.
48. Sobell H. Actinomycin and DNA transcription. Proc Natl Acad Sci USA 1985; 82: 5328-5331.
49. Baliga B, Pronczuk A, Munro H. Mechanism of cycloheximide inhibition of protein synthesis in a cell-free system prepared from rat liver. JBC 1969; 244: 4480-4489.
50. Mansvelder H, Kits K. The relation of exocytosis and rapid endocytosis to calcium entry evoked by short repetitive depolarizing pulses in rat melanotropic cells. J Neurosci 1998; 18: 81-92.
51. Neves G, Gomis A, Lagnado L. Calcium influx selects the fast mode of endocytosis in the synaptic terminal of retinal bipolar cells. Proc Natl Acad Sci USA 2001; 98: 15282-15287.
52. Lundgren M, Persson U, Larsson P, et al. Interleukin 4 induces synthesis of IgE and IgG4 in human B cells. Eur J Immunol 1989; 19: 1311-1315.
53. Sugawara I, Ishizaka S. The degree of monocyte participation in human B- and T-cell activation by phorbol myristate acetate. Clin Immunol Immunopathol 1983; 26: 299-308.
54. Li E, Stupack D, Bokoch G, Nemerow G. Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases. J Virol 1998; 72: 8806-8812.
55. Park H, Lee K, Kim S, Lee Y, Koh S. L-DOPA-induced neurotoxicity is reduced by the activation of the PI3K signaling pathway. Toxicology 2009; 265: 80-86.